Location History:
- Rockville, MD (US) (1989 - 1991)
- Fayetteville, NY (US) (1990 - 1991)
Company Filing History:
2 out of 2 
2 out of 11 Years Active: 1989-1991
Title: Moo K Park: Innovator in Pharmaceutical Compositions
Introduction
Moo K Park is a notable inventor based in Fayetteville, NY (US), recognized for his contributions to the field of pharmaceutical compositions. With a total of four patents to his name, he has made significant advancements in the formulation of oral medications.
Latest Patents
Among his latest patents is a liquid oral pharmaceutical composition of non-steroidal anti-inflammatory drugs (NSAIDs). This innovative one-phase liquid composition is designed for oral administration and includes an NSAID such as an indoleacetic acid derivative or a pyrroleacetic acid derivative, combined with a di- or triglyceride of a medium-chain fatty acid edible oil. This formulation acts as a pharmaceutical solvent carrier, while ensuring that ethanol or other monohydric alcohol solvents are absent. Another significant patent involves a method for preparing high potency sucralfate. This process yields sucralfate in a newly useful form by first reacting sucrose with chlorosulfonic acid in 2-picoline, followed by the formation of an ammonium salt that is reacted with aluminum chlorohydrate in a specific sequence using an alcoholic solvent. The resulting products exhibit unexpected pharmaceutical and physical characteristics, emphasizing the critical formulation of oral liquid suspensions.
Career Highlights
Moo K Park has worked with several companies throughout his career, including Formulations Development Labs and Applied Analytical Industries, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and innovations.
Collaborations
He has collaborated with notable coworkers such as Henry C Caldwell and Nick V Lazaridis, further enhancing his work in the pharmaceutical field.
Conclusion
Moo K Park's innovative contributions to pharmaceutical compositions demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of formulation chemistry and a dedication to improving patient care through effective medication delivery systems.